Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × Norethindrone Acetate × Clear all

Phase

Status

Sponsor Class

INDUSTRY 4 OTHER 1 NIH 1

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 1751 Radiotherapy 1609 Cisplatin 1539 Carboplatin 1307 Gemcitabine 1213 Paclitaxel 1110 Bevacizumab 1070 Docetaxel 1053 pembrolizumab 1029 Capecitabine 993 Oxaliplatin 987 Fluorouracil 923 Dexamethasone 837 Rituximab 785 Nivolumab 780 Magnetic Resonance Spectroscopy 735 Etoposide 711 Doxorubicin 704 Radiosurgery 666 Irinotecan 666 Drug Therapy 663 Cytarabine 640 fludarabine 621 Leucovorin 584 Lenalidomide 529 fludarabine phosphate 486 Temozolomide 471 Radiation 470 Filgrastim 466 Cetuximab 458

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01160315 2015-10-30

Erasme-POF

Erasme University Hospital

Phase 2/3 Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡